The role of radiotherapy in ovarian cancer

被引：15

作者：

Durno, Kimberley ^{[1
]}

Powell, Melanie E. ^{[1
]}

机构：

[1] St Bartholomews Hosp, Clin Oncol, London EC1A 7BE, England

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷 / 03期

关键词：

ovarian cancer; radiation; quality of life (pro); palliative care; PALLIATIVE RADIATION-THERAPY; WHOLE ABDOMINAL RADIOTHERAPY; CLEAR-CELL CARCINOMA; PROGNOSTIC-FACTORS; CHEMOTHERAPY; RECURRENT; TRIAL; IRRADIATION; MANAGEMENT; SURVIVAL;

D O I：

10.1136/ijgc-2021-002462

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epithelial ovarian cancer accounts for around 1.9% of all malignancies and often presents late at an advanced stage. Prognosis is therefore poor. Currently the mainstay of treatment is radical cytoreductive surgery and chemotherapy but, in the past, the standard of care also included adjuvant whole abdominal radiotherapy. This is no longer standard practice, largely due to high toxicity rates and the effectiveness of platinum-based chemotherapy. Presently, a role is emerging for modern radiotherapy techniques in both the salvage and palliative settings. This review aims to examine the historical use of radiotherapy in ovarian cancer before looking forward to its potential future role.

引用

页码：366 / 371

页数：6

共 50 条

[21] Role of a multidisciplinary team in administering radiotherapy for esophageal cancer
Zhao, Shengguang
Qi, Weixiang
Chen, Jiayi
BMC CANCER, 2020, 20 (01)
[22] The role of radiotherapy in urinary bladder cancer: current status
Marta, Gustavo Nader
Hanna, Samir Abdallah
Gadia, Rafael
Miranda Correa, Sebastiao Francisco
Fernandes da Silva, Joao Luis
Carvalho, Heloisa de Andrade
INTERNATIONAL BRAZ J UROL, 2012, 38 (02): : 144 - 153
[23] Radiation Therapy in Ovarian Cancer: An Overview and Future Directions
McCormack, M.
CLINICAL ONCOLOGY, 2018, 30 (08) : 504 - 506
[24] Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
Kim, S., I
Kim, J-W
ESMO OPEN, 2021, 6 (03)
[25] Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer
Teo, Melissa C. C.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 3 - 8
[26] The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer
Nusrat, Osama
Belotte, Jimmy
Fletcher, Nicole M.
Memaj, Ira
Saed, Mohammed G.
Diamond, Michael P.
Saed, Ghassan M.
REPRODUCTIVE SCIENCES, 2016, 23 (11) : 1484 - 1492
[27] The role of Cediranib in ovarian cancer
Orbegoso, Cecilia
Marquina, Gloria
George, Angela
Banerjee, Susana
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1637 - 1648
[28] Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer
Zhang, B.
Pan, J. -S.
Liu, J. -Y.
Han, S. -P.
Hu, G.
Wang, B.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2006, 28 (09): : 619 - 625
[29] Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers
Swenerton, K. D.
Santos, J. L.
Gilks, C. B.
Koebel, M.
Hoskins, P. J.
Wong, F.
Le, N. D.
ANNALS OF ONCOLOGY, 2011, 22 (02) : 341 - 347
[30] Radiotherapy in women with epithelial ovarian cancer: historical role, current advances, and indications
Haydee Flores-Balcazar, Christian
Maria Urias-Arce, Dulce
CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)

← 1 2 3 4 5 →